EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

Marie Masson Regnault iD, Emilie Brenaut, Marie-Emeline Marniquet iD, Carla Berthault, Lea Canoen, Clarisse Marcombes, Audrey Melin, Raphaël Ouakrat iD, Julie Charles, Stephane Mouret, Olivier Potie, Laetitia Penso und 15 weitere

Journal of the European Academy of Dermatology and Venereology · 2026-06 · 40 (6) · 963-979

DOI: 10.1111/jdv.70263 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 30.12.2025. Verfasst von Marie Masson Regnault und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Polyclinique Francheville, Périgueux, France. Hauptthemen laut MEDLINE: Psoriasis, Dermatologic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current French guidelines for the treatment of psoriasis date from 2019 and do not include the most up‐to‐date interventions. The Psoriasis Research Group of the French Society of Dermatology has developed new guidelines to provide updated decision‐making algorithms for the systemic treatment of adult patients with moderate‐to‐severe psoriasis. The algorithms were created following a thorough review of existing psoriasis treatment guidelines and recent publications on new systemic therapies not included in previous recommendations. They propose updated treatment strategies that combine established and emerging systemic therapies for patients with plaque psoriasis and psoriatic arthritis. The working group recommends methotrexate, adalimumab or ustekinumab as the primary systemic treatment for patients with psoriasis without symptomatic comorbidities. Additionally, the guidelines include specific recommendations for long‐term management in cases of insufficient response or low disease activity, as well as for treating specific types of psoriasis and managing patients with comorbid conditions or those planning a pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisDermatologic AgentsHumansFranceAdultSeverity of Illness IndexUstekinumabAdalimumabMethotrexateAlgorithmsPractice Guidelines as TopicFemale

Stichwörter der Autor:innen

HIV infectionsarthritisatherosclerosisbiological therapydepressiondiabetes mellitusguidelinesheart diseaseshepatitis Bhepatitis Cinflammatory bowel diseaseskidney diseasesliver diseasesmultiple sclerosisneoplasms

Substanzen

Dermatologic AgentsUstekinumabAdalimumabMethotrexate

Autor:innen und Institutionen

  • Department of Dermatology, Polyclinique Francheville, Périgueux, France.
  • Department of Dermatology, CHU de Brest, Brest, France.
  • Department of Dermatology, CHU de Nantes, Nantes, France.
  • Department of Dermatology, CHU Henri Mondor, Créteil, France.
  • Department of Dermatology, CHU de Grenoble, Grenoble, France.
  • Department of Epidemiology, Université Paris-Est Créteil (UPEC), Créteil, France.

ORCID-Profile: Marie Masson Regnault, Marie-Emeline Marniquet, Raphaël Ouakrat, Clara Labonne, Tania Randriamiarana, Marine Chastagner, Emilie Sbidian, Hélène Aubert

Zitieren

APA

Masson Regnault, M., Brenaut, E., Marniquet, M. E., Berthault, C., Canoen, L., Marcombes, C., Melin, A., Ouakrat, R., Charles, J., Mouret, S., Potie, O., Penso, L., Vegas, L. P., Larid, G., Roux, M., Bougeard, C., Sylvain, S., Labonne, C., Randriamiarana, T., …, & Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie) (2026). French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025. Journal of the European Academy of Dermatology and Venereology, 40(6), 963-979. https://doi.org/10.1111/jdv.70263

Vancouver

Masson Regnault M, Brenaut E, Marniquet ME, Berthault C, Canoen L, Marcombes C, et al. French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025. Journal of the European Academy of Dermatology and Venereology. 2026;40(6):963-979. doi:10.1111/jdv.70263

BibTeX
@article{MassonRegnault2026,
  author = {Masson Regnault, Marie and Brenaut, Emilie and Marniquet, Marie-Emeline and Berthault, Carla and Canoen, Lea and Marcombes, Clarisse and Melin, Audrey and Ouakrat, Raphaël and Charles, Julie and Mouret, Stephane and Potie, Olivier and Penso, Laetitia and Vegas, Laura Pina and Larid, Guillaume and Roux, Marine and Bougeard, Colombe and Sylvain, Sandy and Labonne, Clara and Randriamiarana, Tania and Pitaud, Da Hee and Etheve, Floriane and Gottlieb, Jeremy and Gouillon, Laurie and Chastagner, Marine and Sbidian, Emilie and Aubert, Hélène and Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie), Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie)},
  title = {French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {963--979},
  doi = {10.1111/jdv.70263}
}
Kostenlos starten →